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Microbeads for bone repair have been widely studied because they can be conveniently used 
in clinical applications. This study concerns the preparation, physical properties and in vitro 
characterisation of different types of alginate / calcium phosphate (CaP) ceramic microbeads, 
which were designed for use as drug delivery systems and bone-regeneration matrices. Hybrid 
microbeads were successfully prepared from sodium alginate and various CaP, namely α-
tricalcium phosphate, β-tricalcium phosphate and hydroxyapatite using the liquid droplet 
method. Porosity, swelling properties and in vitro degradation of the microbeads in aqueous 
environment were significantly changed by the added CaP. The compressive strength of the 
blocks fabricated from the beads was around 120 MPa irrespective of the type of CaP. The 
initial release rate of the model drug methylene blue was suppressed by the addition of CaP. 
The alginate-CaP composite beads hold promising potential as an encapsulation carrier of 
drugs and component of bone substitutes. 
 




1.  Introduction 
 Calcium phosphates (CaP) are recognized as a useful biomaterial in hard tissue 
regeneration [1] because of their osteoconductivity and efficacy in most clinical applications 
in orthopaedics and dentistry[2] . Hydroxyapatite (HAp; Ca10(PO4)6(OH)2] exhibits excellent 
biocompatibility because of its similarity in composition to natural bone [3]. Apart from HAp, 
α-tricalcium phosphate (α-TCP; α-Ca3(PO4)2) and β-tricalcium phosphate (β-TCP; β-
Ca3(PO4)2) have been widely studied as materials for bone repair owing to their outstanding 
biocompatibility, bioactivity and high osteoconductivity. For all forms of bone graft, a 
spherical shape of the material could be useful for uniform packing in sporadically shaped 
defects [4] . 
 Researchers have recently focused heavily on the binding of ceramic bone grafts with 
bioactive molecules for osteoinductivity and osteogenesis [5], and on refining osteogenic 
properties of bone grafts used for bony defects. The binding of biomolecules to ceramics that 
allows a controlled release of the laden biomolecules via the binding mode has proved 
difficult. Numerous biomaterials and their derivatives such as alginate [6-7], chitosan [8-9], 
agarose [10-11], gelatin [12-13], collagen[14-15] and fibroin[16] have been studied for 
regeneration of osteochondral interfaces or articular cartilage tissues because of their inherent 
biocompatibility, non-toxicity and biodegradability. 
 Although natural materials allow favourable biological interactions with host tissues, 
the low mechanical strength and instability of the materials compared with the native cartilage 
sometimes complicate their clinical applications [17]. Alginate is considered to be 
biocompatible, non-toxic; non-immunogenic and biodegradable. Given its natural abundance 
and low cost, it has been widely used as thickener and emulsifying agent in the food industry 
and as tissue engineering material. The choice of alginate as a polymeric vehicle can be 
attributed to its favourable properties and versatility. Sodium alginate and most other 
alginates from monovalent metals are soluble in water, forming solutions of considerable 
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viscosity. Alginate can be easily modified in any form such as hydrogels, microbeads, 
microcapsules, sponges, foams and fibres, allowing increased applications in various fields 
such as tissue engineering and drug delivery. Alginate can be chemically or physically 
modified for tuning of its biodegradability, mechanical strength, gelation property and cell 
affinity towards respective applications [18]. 
 Various alginate-CaP hybrids have been developed as synergetic systems for bone 
regeneration in the form of microspheres [4], cement [19,20], bulk porous scaffold [21-23]. In 
the case of microsphere preparation, HAp and calcium titanium phosphate were selected as 
and inorganic phase and enzyme release was evaluated [4]. However, no comparative studies 
of alginate-based hybrid beads with various CaP such as HAp, α-TCP and β-TCP prepared by 
the same experimental conditions have been reported on applications in interfacial 
osteochondral defects or drug delivery vehicles for hard tissue regeneration. In addition, 
although several hybrid microspheres have been developed from CaP and polylactide, a 
representative synthetic biodegradable polymer [24,25], effects of CaP have not been 
sufficiently revealed. If such points are clarified, it is expected that fundamental design for the 
hybrids with varied biological properties and drug delivery ability can be established. 
 In our pursuit, we performed a comparative study by combining α-TCP, β-TCP or HAp 
with sodium alginate, a natural polysaccharide that has been shown to be biocompatible. This 
work describes the preparation and initial characterisation of the alginate microbeads with and 
without CaP, designed as injectable drug delivery matrices and bone filling materials.  
 





Sodium alginate, calcium chloride (CaCl2), methylene blue were purchased from Wako 
Pure Chemical Industries, Ltd., Osaka, Japan. α-Tricalcium phosphate (α-TCP-B) and β-
tricalcium phosphate (β-TCP-100) were purchased from Taihei Chemical Industrial Co., 
Osaka, Japan and HAp was purchased from Central Glass Co., Ltd., Tokyo Japan. Ultrapure 
water (prepared using Direct-Q, Nihon Millipore K.K., Tokyo, Japan) was employed for 
experimental purposes. 
 
2.2. Preparation of alginate and alginate hybrid beads 
Sodium alginate was dissolved in deionized water to a final concentration of 4% (w/v) 
with and without equal weight ratio of α-TCP, β-TCP or HAp. Pure and hybrid alginate beads 
were prepared by dripping the 4 mass% sodium alginate solution into CaCl2 under constant 
stirring at room temperature. The droplets were left for 1 hour in the gelling bath before being 
removed and rinsed with distilled water.  
 
2.3. Material characterisation 
 The surface structural changes of the samples were characterised using a scanning 
electron microscope (SEM; Model S-3500N; Hitachi Co., Tokyo, Japan), an energy 
dispersive X-ray analyser (EDX; Model EX-400; Horiba Co., Kyoto, Japan), X-ray 
diffractometer (XRD; MXP3V; Mac Science Ltd., Yokohama, Japan) and Fourier-transform 
infrared spectrometer (FT-IR, FT/IR-6100, JASCO Co., Tokyo, Japan). For FT-IR, the gels 
were first pulverised and mixed with KBr powder at a mass ratio of 1:100. A thin film was 
prepared by uniaxially pressing the mixed powder to measurement. 
 
2.4. Porosity and density measurements 
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 The density and porosity of the prepared samples were measured by water displacement. 
A sample with a known weight w1 was immersed in a beaker holding a known volume v1 of 
water. A series of brief evacuation-repressurisation cycle were performed to force the water 
into the samples. Then the total volume of the water plus the water-impregnated samples (v2) 
and the volume of the residual water after the water-impregnated samples were removed (v3) 
were recorded. The density of the sample (d) and the porosity of the sample (ε) are expressed 
as follows: 
 
d = w1/(v2−v3)---------------(1) 
    ε=(v1−v3)/(v2−v3)×100-----------(2) 
 
2.5. Swelling ratios of beads 
 The weights of the dried beads and beads immersed in deionized water for 48 h at room 
temperature were determined. In brief, the pre-weighed, dried hybrid beads were immersed in 
50 ml of ultrapure water at 25 °C for 24 h. At a regular time interval (1 h), the hybrid beads 
were taken out from ultrapure water, the surface water was blotted off with tissue paper and 
then reweighed. The experiment was carried out until the equilibrium weights of the films 
were reached. The swelling ratio was evaluated using: 
 
                        Swelling ratio (%)  =  (Ws−Wd)/Wd ×100 ---------(3) 
 
where Ws is the weight of the water-swollen beads and Wd is the weight of the dried beads. 
 
2.6. In vitro degradation  
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 The alginate/alginate hybrid hydrogels were incubated in 20.0 ml of saline solution at 
37 °C. Gel degradation behaviour was monitored by measuring the dry weight loss over time. 
At least four samples at each time point were used to obtain the weight loss curve. 
Experiments were done under sterile conditions to prevent bacterial and fungal contamination. 
 
2.7. Mechanical properties 
 The mechanical strength of the samples was evaluated in terms of compressive strength. 
For the purpose, we used moulds made with cylindrical cavities in silicon rubber sheets of the 
preferred thickness. Afterwards we coated the outer layer with 50 mass% polyacrylic acid 
solution and immediately filled the cavity with the granules, and left it to dry completely for 2 
days. The completely dried samples were pulled out from the silicon sheet. The diameter and 
height of each sample were first measured with a digital micrometre (IP65, Mitutoyo Co., Ltd., 
Kanagawa, Japan). Each sample was crashed at a crosshead speed of 1 mm/min using a 
universal testing machine (Autograph AGS-J, Shimadzu, Kyoto, Japan). The average of eight 
samples was taken as the value of compressive strength. 
 
2.8. In vitro release of model drug 
 Methylene blue was used as a model drug to evaluate the performance of the calcium 
alginate beads in controlled drug delivery. Thirty samples of calcium alginate beads were 
equilibrated in a 30-ml methylene blue solution (500 mg/ml) for 24 hours. The beads were 
rinsed thrice before the drug release studies. The release profile of methylene blue was studied 
using a UV-Vis spectrophotometer. The concentration of methylene blue was determined 
spectrophotometrically at 664.5 nm. 
 
2.9. Statistical analysis 
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All values were analysed by one-way analysis of variance followed by Turkey's multiple 
comparison tests. Significant differences were assumed at p < 0.05. 
 
3.  Results 
 Figure 1 illustrates the typical optical and SEM photographs of the prepared beads. 
There were no significant differences in the shape and size of the granules at macroscopic 
level. However, at higher magnification differences could be clearly observed in terms of 
roughness and shape. Alginate and Alginate/HAp showed numerous cracks. 
 
 
Figure 1  Digital photographs and SEM images of the prepared beads after drying. 
 
 Figure 2 shows the XRD patterns of the prepared beads. Alginate showed a broad peak 
at 2θ=13.7°, consistent with its amorphous nature [26,27]. The other samples demonstrated 
peaks corresponding to each CaP (α-TCP: JCPDS card 9–348, β-TCP: JCPDS card 9-169 and 





Figure 2  XRD patterns of the prepared beads after drying. 
 
 Figure 3 presents the FT-IR spectra of Alginate/α-TCP, Alginate/β-TCP and 
Alginate/HAp hybrid beads. Peaks of P-O characteristic of CaP were observed for all the 
samples around 550–500 and 950–1050 cm−1[28,29]. According to Ma et al., HAp should 
have a strong absorption band around 1035 cm−1 due to the stretching of PO43−[28]. However, 
it is well known that sodium alginate also has a strong absorption band of C–O–C at this 
wavenumber [30]. Thus, the observed P-O band of Alginate/HAp around 1035 cm−1 would be 
very weak.  
 




 Swelling behaviour is a very important property of a drug delivery vehicle, because it 
has a great influence on the control of drug release. Figure 4 describes the swelling ratio of 
the samples in ultrapure water at 37 °C. The hybrid beads reached their equilibrium swelling 
state at around 15 hours. In the first 12 hours, the swelling ratio decreased in the order: 
Alginate∼Alginate/α-TCP>Alginate/HAp∼Alginate/β-TCP. After 24 hours, it decreased in 
the order: Alginate>Alginate/HAp>Alginate/α-TCP>Alginate/β-TCP.  
 
 
Figure 4  Swelling ratio of the prepared beads after immersion in ultrapure water for various 
periods (n=3). 
 
 Figure 5 describes the density and porosity of the prepared samples. The density 
decreased in the order: Alginate/HAp>Alginate/β-TCP>Alginate/α-TCP>Alginate. The 
porosity of Alginate was around 65%, while those of the other samples were around 30% 
irrespective of the kind of CaP. There were distinct differences in the density and porosity 
among the samples. The added CaP was assumed to fill the pores in the alginate matrix, 






Figure 5  Density and porosity of the prepared beads. 
 
 As a preliminary model of bioabsorption of the beads in an injection site, degradation 
was monitored in vitro by measuring the dry weight of the samples as a function of incubation 
time in saline at 37 °C (Fig. 6). Weight loss after 35 days decreased in the order: 
Alginate>Alginate/β-TCP>Alginate/α-TCP>Alginate/HAp. The SEM images for the beads 
before and after immersion in PBS are shown in Fig. 7. Although a lot of pores were formed 
in Alginate after immersion, significant changes in size and shape were not observed. It was 
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found that addition of CaP to the alginate beads suppressed degradation in the aqueous 
environment, and this phenomenon would be induced by suppression of the swelling. 
 
 
Figure 6  Degradation rate in vitro of the prepared beads in a saline solution at 37°C for 
various time periods (n=4). 
 
 Blocks fabricated from each kind of beads were tested for their compressive strength 
(Fig. 8). Equal weights and volumes were maintained throughout the experiment to maintain 
the homogeneity of the system. The compressive strength of the blocks of Alginate, 
Alginate/α-TCP, Alginate/β-TCP and Alginate/HAp were 122.84±4.39, 125.52±11.2, 
119.37±7.84 and 129.26±12.4 MPa respectively. 
 Figure 9 shows the release profiles of methylene blue from the beads. Alginate showed 
a burst release profile. The t50 value (50% of drug release) for alginate was 55 minutes 







Figure 7  SEM photographs of the prepared beads before and after immersion in saline at 
37°C for 35 days. 
 
 





Figure 9  In vitro release profiles of methylene blue from the prepared  beads. 
 
4.  Discussion 
 Composite microspheres of alginate and various CaP were prepared through gelation 
by Ca2+. XRD results indicate that the amorphous nature of alginate is diminished by the 
accumulation of CaP particles (See Fig. 2). The crystallinity of each CaP was confirmed to 
remain intact in the ionically cross-linked polymer network, which may affect the mechanical 
properties of the hybrids. 
 Addition of HAp or β-TCP to the alginate microspheres decreased swelling ratio in 
aqueous conditions (See Fig. 4). In pure alginate, the large number of hydrophilic groups and 
the void space in the cross-linked network would lead to the highest swelling ratio. Addition 
of HAp or β-TCP to alginate beads was found to suppress the initial swelling in the aqueous 
environment. Ionic interactions between alginate and the added CaP would block significant 
water penetration. Meanwhile, Alginate/α-TCP showed a similar swelling profile to alginate. 
α-TCP could easily react with the surrounding water to convert into low crystalline HAp [31]. 
Therefore, a large amount of water could presumably penetrate into Alginate/α-TCP. In the 
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case of Alginate/HAp, the swelling ratio significantly increased after 12 hours to resemble 
that of alginate. This could possibly be due to the degradation of the interface between 
alginate and HAp by the swelling, although detailed structural changes should be further 
analysed. Improvement of chemical bonding between alginate and HAp particles by silane 
coupling agents may suppress the significant swelling at the later stage. 
 Compressive strength of the blocks fabricated by accumulation of the microspheres 
was more than 100 MPa irrespective of inorganic phase (See Fig. 8). It is assumed that 
intergranular voids in the blocks are filled with polyacrylic acid even in pure alginate. The 
measured compressive strength of the hybrid blocks is comparable to that of typical glass 
ionomer cements [32]. Tanahashi et al. have demonstrated that carboxyl groups in organic 
polymers form tight ion-ion interactions with Ca2+ [33]. Therefore, similar interactions may 
exist between CaP and the carboxyl groups in alginate and/or the polyacrylic acid in the 
present samples. Blocks fabricated from the microbeads are thus expected to be useful 
materials for bone substitutes. For this purpose, not only compressive but also bending 
strength is important and it should be clarified in future. In order to enhance the bending 
strength, reinforcement of the interface between the constituent phases is important. In this 
study, ionic polyacrylic acid was used as a binder for fabrication of the blocks. This would 
enhance bonding of each microsphere, since components of the microspheres have also ionic 
characteristics.  
 It was found that incorporation of CaP into the alginate beads is effective for slow 
release of methylene blue (See Fig. 9) This can be attributed to the suppression of swelling 
and biodegradation (See Figs. 4 and 6). Moreover, CaP likely adsorbs methylene blue tightly 
onto their surfaces, having a larger quantity of ionic functional groups than alginate. Notably, 
the initial release rate of Alginate/HAp was higher than that of Alginate/β-TCP. β-TCP is 
reportedly more negatively charged than HAp [34], thus the former adsorbs the positively 
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charged methylene blue more tightly than the latter. This has implications in the selection of 
the appropriate kind of CaP according to the target drug to obtain the desired drug release 
profile. 
 In order to further understand the release behaviour, the release data were investigated 
by fitting the cumulative release data. Several mathematical equation models describe drug 
dissolution and/or release from DDS. In the modern era of controlled-release oral 
formulations, ‘Higuchi equation’ has become a prominent kinetic equation in its own right, as 
evidenced by employing drug dissolution studies that are recognized as an important element 
in drug delivery development [35]. After simplifying the above equation, Higuchi equation 
can be represented in the simplified form: 
Q = KH x t ½ ------------(4) 
where KH is the Higuchi dissolution constant. 
The data obtained were plotted as cumulative percentage drug release versus square root of 
time. Therefore, the simple Higuchi model will result a linear Q versus t1/2 plot having 
gradient, or slope, equal to KH and we say the matrix follows t1/2 kinetics.   
 For detailed kinetic study, we have selected the initial period drug release data from 5 
to 120 minutes. The cumulative % drug release vs. square root of time graph has been plotted. 
As shown in Fig. 10, it is clear that all the set of prepared beads may follow the Higuchi 
square root model. It was noticed that higher correlation coefficient was observed in case of 
Alginate/α-TCP and Alginate/HAp (0.99), but in case of Alginate and Alginate/β-TCP sphere 
it was 0.98. Hence, we can say that the drug release profile of methylene blue as model drug 
from the developed spheres mainly follows diffusion-controlled release mechanism at initial 




Figure 10 Higuchi model kinetic release of methylene blue from prepared beads. 
 
 The obtained hybrid microspheres are expected to be applied for a drug delivery 
carrier. Many studies on in vitro and in vivo comparisons of drug release of polymer 
microspheres have been reported [36,37], but not many of inorganic materials. Wang et al. 
prepared microspheres with average particle size of 14.3 µm in which the doxycycline was 
incorporated into poly(lactide-co-glycolide) (PLGA)-coated HAp microspheres, and 
compared their release behavior in vitro and in vivo [38]. The controlled release 
characteristics were improved by the PLGA coating. Furthermore, 40% of the contained 
doxorubicin was released in 150 h or more in vitro, and the steady concentration was 
maintained in mouse plasma. On the other hand, although the incorporated substances were 
different, the microspheres produced in this study released 40% of the methylene blue in 1 to 
5 h. The main reason for these phenomena is thought to be the difference in hydrophobicity of 
the polymers. It is assumed that PLGA suppressed the penetration of the surrounding water 
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into the microspheres due to its hydrophobicity and contributed to the controlled release. In 
future study, control in the hydrophobicity of the polymers to optimize the drug release 
behavior is also needed. 
 
5.  Conclusions 
In this work, we performed a comparative study on alginate-based composite beads 
modified with various kinds of CaP. Particles with high sphericity were obtained irrespective 
of the kind of CaP. There were no significant differences in the mechanical behaviour of the 
blocks fabricated from the beads. The swelling properties and in vitro release profile of 
methylene blue differed between the beads of different CaP. The drug release profile of from 
the developed spheres is following diffusion-controlled release mechanism. The approach 
used in this study not only enhanced the bead strength substantially, but also prolonged the 
bead dissolution for controlled release of drugs. We have successfully demonstrated that 
microbeads with a suitable release profile for the target drug can be obtained by fabrication 
from alginate and the appropriate kind of CaP.  
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